Lupin Launches Azilsartan Medoxomil Tablets in U.S. Market
MUMBAI, India & NAPLES, Fla., June 17, 2026 Lupin Limited, a leading global pharmaceutical company, has announced the launch...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MUMBAI, India & NAPLES, Fla., June 17, 2026 Lupin Limited, a leading global pharmaceutical company, has announced the launch...
LOS ANGELES, Calif., June 18, 2026 TORL BioTherapeutics has reported encouraging preliminary Phase 1 clinical data for its investigational...
